According to Dr Yang the institute will not merely compare healthy and tumorous tissue from the same individuals, as the International Cancer Genome Consortium (of which it is a part) plans to do, it will actually be able to follow the pattern of mutation, in the order that it happened, within an individual that has led to his cancer.
ECONOMIST: The next advances in genomics may happen in China